Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03434795
Other study ID # 2011_40
Secondary ID 91218012-272
Status Completed
Phase N/A
First received January 18, 2018
Last updated February 13, 2018
Start date May 2012
Est. completion date May 2017

Study information

Verified date February 2018
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluate the reproducibility and validate a posteriori a new rule of clinical decision on a multi-center population of children with a post-chemotherapy febrile neutropenia


Recruitment information / eligibility

Status Completed
Enrollment 1900
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender All
Age group 1 Year to 18 Years
Eligibility Inclusion Criteria:

- Child aged 1 to 18 years

- Child with hematology or cancer

- Child with a febrile neutropenia post-chemotherapy

- Child with social security

- No opposition from the child and/or parents, in case of absence, the holder of the parental authority present, can consent, alone, to the participation of the unemancipated minor.

Exclusion Criteria:

- Febrile neutropenia at diagnosis of tumor disease

- Child with palliative care

- Child having had a hematopoietic stem cell allo-graft in the preceding year

- Febrile neutropenia immediately post auto-transplant

- Antibiotherapy prior to admission

- Initial care in a non-investigative center.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Hôpital Jeanne de Flandre - CHRU de Lille Lille

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Lille Ligue contre le cancer, France, Ministry of Health, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood culture Presence or not of bacteriemia On average between 5 days and 1 month
Primary Positive bacterial culture from a normally sterile site Presence or not of bacterial infection on average between 5 days and 1 month
Primary microbiological culture Presence or not of focal infection at high risk of dissemination was defined as any local infection with or without microbiological documentation into a normally sterile site, with significant risk of loco-regional or systemic spread On average between 5 days and 1 month
Primary Fungal culture Presence or not of fungal infection is referred to a proven, probable, or possible fungal infection as defined by the IFICG ot the EORTC On average between 5 days and 1 month